Skip to main content
Fig. 1 | Journal of Neuroinflammation

Fig. 1

From: Captopril alleviates epilepsy and cognitive impairment by attenuation of C3-mediated inflammation and synaptic phagocytosis

Fig. 1

Captopril treatment attenuates the KA-induced epilepsy in rats. A The experimental design is shown. B Representative 2 min EEG recording during epilepsy (7 weeks after KA induction) indicates the captopril treatment significantly suppresses the KA-induced recurrent seizures. C, D Quantification of the frequency and total seizure duration validates the captopril treatment significantly suppresses the KA-induced recurrent seizures. n = 6 rats/group, *p < 0.05, **p < 0.01, Student’s t test. Data are presented as mean ± SE

Back to article page

Journal of Neuroinflammation

ISSN: 1742-2094